Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    63
    CASES:
    63
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    7
    Column number:
    9
    Tissue Array Type:
    FFPE
    Species:
    Human
FUR631
$225.00
Add To Collect

Description: Endometrioid cancer tissue array, including pathology grade, TNM and clinical stage, 63 cases/63 cores

Details: Endometrioid carcinoma tissue microarray, containing 60 cases endometrioid adenocarcinoma, plus 3 endometrial tissue tissue, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • NAT(*)
  • Normal(*)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIC)
  • _ma
TISSUE ARRAYS
FUR631
1
2
3
4
5
6
7
8
9
A
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
B
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
C
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
D
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
E
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
F
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
G
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
_ma
FUR631
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 35 F Uterus Endometrioid adenocarcinoma (sparse) 1 T2N0M0 II Malignant *
A2
2 57 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant *
A3
3 57 F Uterus Endometrioid adenocarcinoma (sparse) 1 T1bN0M0 IB Malignant *
A4
4 38 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant *
A5
5 49 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 5*5
A6
6 47 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 9*9
A7
7 56 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 3*2.5*1.2
A8
8 53 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 6*4*4
A9
9 54 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 2.5*2*0.5
B1
10 50 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 11*10*4
B2
11 37 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 6*4.5*3
B3
12 53 F Uterus Endometrioid adenocarcinoma (sparse) 1 T1aN0M0 IA Malignant 9*8*8
B4
13 68 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 7*4*4
B5
14 54 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 2*1.5*1
B6
15 43 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 8*7*6
B7
16 49 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 2.5*1
B8
17 50 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 4*2
B9
18 43 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 2*2
C1
19 53 F Uterus Endometrioid adenocarcinoma 1 T2N0M0 II Malignant 9*9*4
C2
20 37 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 4*3*1.5
C3
21 33 F Uterus Endometrioid adenocarcinoma 1--2 T1bN0M0 IB Malignant 11*9*4
C4
22 56 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 5*3.5
C5
23 70 F Uterus Endometrioid adenocarcinoma 2 T1bN1M0 IIIC Malignant 6*4*4
C6
24 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 4*3*2
C7
25 46 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 3.5*2*0.8
C8
26 61 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant 3*2
C9
27 70 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 9*3.5*2.5
D1
28 30 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant *
D2
29 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant *
D3
30 52 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
D4
31 58 F Uterus Endometrioid adenocarcinoma (sparse) 2 T1aN0M0 IA Malignant *
D5
32 46 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
D6
33 74 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 3*3*2
D7
34 59 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 8*3*2.5
D8
35 54 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant 2.5*2*1
D9
36 50 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 3*2
E1
37 70 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant 1.5*4.5*2
E2
38 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 4*3*2
E3
39 68 F Uterus Endometrioid adenocarcinoma 2 T3aN0M0 IIIA Malignant 8*6*4
E4
40 54 F Uterus Endometrioid adenocarcinoma with necrosis 2 T1aN0M0 IA Malignant 9*5*3
E5
41 50 F Uterus Endometrioid adenocarcinoma 2 T3aN0M0 IIIA Malignant 6*4*2.5
E6
42 58 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 5*3*3
E7
43 43 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 7*3*3
E8
44 79 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 4*3*0.8
E9
45 60 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 5*5*3
F1
46 63 F Uterus Endometrioid adenocarcinoma with necrosis 2--3 T3aN0M0 IIIA Malignant 9*3*2.5
F2
47 58 F Uterus Endometrioid adenocarcinoma with necrosis 2--3 T1bN0M0 IB Malignant 10*9*7
F3
48 49 F Uterus Endometrioid adenocarcinoma 3 T2N0M0 II Malignant 5*5*4
F4
49 53 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant 7*6*4
F5
50 60 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant 4*3*2.5
F6
51 51 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 8*4.5*4.5
F7
52 51 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant 4*3
F8
53 53 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 4*2.5*1.5
F9
54 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3.5*3*1.2
G1
55 43 F Uterus Endometrioid adenocarcinoma with necrosis 3 T1bN0M0 IB Malignant 3.5*3*2.5
G2
56 66 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant *
G3
57 63 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant *
G4
58 55 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant *
G5
59 52 F Uterus Endometrioid adenocarcinoma 3 T2bN0M0 IIB Malignant *
G6
60 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3*2*1
G7
61 52 F Uterus Endometrial tissue * * * NAT *
G8
62 46 F Uterus Endometrial tissue * * * NAT *
G9
63 54 F Uterus Endometrial tissue * * * Normal *
_marker_
Find overlapping cases with this tissue array:
  • FUR631
    File Format: .xlsx
    Release Date: 2025-01-17 16:01:04
    Download
2.037569s